{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:25:43Z","timestamp":1778793943828,"version":"3.51.4"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ijantimicag.2020.106028","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:38:29Z","timestamp":1590147509000},"page":"106028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["A review on possible modes of action of chloroquine\/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic"],"prefix":"10.1016","volume":"56","author":[{"given":"Satyajit","family":"Tripathy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barsha","family":"Dassarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somenath","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hlupheka","family":"Chabalala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motlalepula Gilbert","family":"Matsabisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.106028_bib0001","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0002","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/jac\/dkv018","article-title":"Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases","volume":"70","author":"Al-Bari","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0003","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.radonc.2013.06.033","article-title":"EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival","volume":"108","author":"Jutten","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/neuonc\/nop046","article-title":"Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells","volume":"12","author":"Kim","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3332\/ecancer.2017.781","article-title":"Repurposing Drugs in Oncology (ReDO)\u2014chloroquine and hydroxychloroquine as anti-cancer agents","volume":"11","author":"Verbaanderd","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-144-5-200603070-00008","article-title":"Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial","volume":"144","author":"Sotelo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0007","article-title":"Chloroquine anticancer activity is mediated by autophagy-independent effects on the tumor vasculature","volume":"3","author":"Maes","year":"2016","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0008","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ijrobp.2013.07.024","article-title":"Chloroquine engages the immune system to eradicate irradiated breast tumors in mice","volume":"87","author":"Ratikan","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0009","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3390\/ijms19113466","article-title":"The roles of autophagy in cancer","volume":"19","author":"Yun","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-12-2464","article-title":"Chloroquine in cancer therapy: a double-edged sword of autophagy","volume":"73","author":"Kimura","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0011","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molmed.2013.04.005","article-title":"Autophagy: shaping the tumor microenvironment and therapeutic response","volume":"19","author":"Maes","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0012","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI117119","article-title":"Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis","volume":"93","author":"Newman","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0013","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1172\/JCI119688","article-title":"Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation","volume":"100","author":"Levitz","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0014","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1086\/322710","article-title":"Adjunctive immune therapy for fungal infections","volume":"33","author":"Gellin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bjid.2012.11.002","article-title":"Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles","volume":"17","author":"Shinde","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0016","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0017","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0018","series-title":"Novel coronavirus (2019-nCoV) situation reports","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2049-9957-3-9","article-title":"Development of antimalarial drugs and their application in China: a historical review","volume":"3","author":"Chen","year":"2014","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ad.2012.10.005","article-title":"Antimalarials in dermatology: mechanism of action, indications, and side effects","volume":"105","author":"Rodriguez-Caruncho","year":"2014","journal-title":"Actas Dermosifiliogr\u00e1f"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0021","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0022","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dsx.2020.03.011","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0023","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1128\/AAC.00067-11","article-title":"Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model","volume":"55","author":"Moore","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0024","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/AAC.01835-10","article-title":"Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine","volume":"55","author":"M\u00fcller","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/AAC.01440-13","article-title":"Distribution of hydroxychloroquine in lymphoid tissue in a rabbit model for HIV infection","volume":"58","author":"Gonz\u00e1lez-Hern\u00e1ndez","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0026","article-title":"Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6\/36 cells","volume":"2013","author":"Silva Farias","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0027","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1348-0421.12154","article-title":"Chloroquine interferes with dengue\u20102 virus replication in U937 cells","volume":"58","author":"Silva Farias","year":"2014","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0028","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2014.03.014","article-title":"Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity","volume":"106","author":"Boonyasuppayakorn","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0029","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12688\/f1000research.6085.2","article-title":"Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry","volume":"4","author":"Long","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0030","doi-asserted-by":"crossref","first-page":"e60579","DOI":"10.1371\/journal.pone.0060579","article-title":"A systematic screen of FDA-approved drugs for inhibitors of biological threat agents","volume":"8","author":"Madrid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0031","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0032","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virology J"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0033","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"De Wilde","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0034","first-page":"17","article-title":"Chikungunya fever\u2014expanded distribution of a re-emerging tropical infectious disease [in German]","volume":"32","author":"Stock","year":"2009","journal-title":"Med Monatsschr Pharm"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0035","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.drudis.2013.05.002","article-title":"Chikungunya virus: an update on antiviral development and challenges","volume":"18","author":"Kaur","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0036","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CVI.00617-13","article-title":"Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine","volume":"21","author":"Leroux-Roels","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0037","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/AAC.01246-09","article-title":"Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation","volume":"54","author":"Martinson","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0038","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.bmc.2015.06.020","article-title":"Anti-HIV screening for cell-penetrating peptides using chloroquine and identification of anti-HIV peptides derived from matrix proteins","volume":"23","author":"Mizuguchi","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0039","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12977-015-0178-0","article-title":"Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV\/AIDS","volume":"12","author":"Savarino","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0041","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0042","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jinf.2013.09.029","article-title":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus","volume":"67","author":"Chan","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0043","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.1175667","article-title":"Chloroquine transport via the malaria parasite's chloroquine resistance transporter","volume":"325","author":"Martin","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0044","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrm2745","article-title":"Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function","volume":"10","author":"Saftig","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0045","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jps.20792","article-title":"Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications","volume":"96","author":"Kaufmann","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0046","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.4049\/jimmunol.1402793","article-title":"Cutting edge: antimalarial drugs inhibit IFN-\u03b2 production through blockade of cyclic GMP\u2013AMP synthase\u2013DNA interaction","volume":"194","author":"An","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0047","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","author":"Zhou","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0048","doi-asserted-by":"crossref","first-page":"e00293","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","author":"Al\u2010Bari","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0049","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines","volume":"186","author":"Ku\u017enik","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0050","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature07405","article-title":"The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor","volume":"456","author":"Ewald","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0051","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"Dijkmans","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0052","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0053","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0054","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"Lai","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0056","doi-asserted-by":"crossref","first-page":"E650","DOI":"10.3390\/v10110650","article-title":"Host lipid rafts play a major role in binding and endocytosis of influenza A virus","volume":"10","author":"Verma","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0057","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbrc.2008.02.023","article-title":"Lipid rafts are involved in SARS-CoV entry into Vero E6 cells","volume":"369","author":"Lu","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0058","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","article-title":"Structural basis for human coronavirus attachment to sialic acid receptors","volume":"26","author":"Tortorici","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0059","first-page":"1","article-title":"Sialic acid receptors of viruses. In: Gerardy-Schahn R, Delannoy P, von Itzstein M, editors","volume":"367","author":"Matrosovich","year":"2013"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0060","article-title":"Increasing host cellular receptor\u2014angiotensin-converting enzyme 2 (ACE2) expression by coronavirus may facilitate 2019-nCoV infection","author":"Wang","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0061","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0063","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1086\/427811","article-title":"Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus","volume":"191","author":"Chen","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection","author":"Fantini","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","author":"Devaux","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0067","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0068","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101663","article-title":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study","volume":"34","author":"Gautret","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0071","doi-asserted-by":"crossref","unstructured":"Rana DR, Dulal S.Therapeutic application of chloroquine and hydroxychloroquine in clinical trials for COVID-19: a systematic review. medRxiv2020 Apr 10. doi: 10.1101\/2020.03.22.20040964.","DOI":"10.1101\/2020.03.22.20040964"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0072","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jmcb\/mjaa014","article-title":"Treating COVID-19 with chloroquine","volume":"12","author":"Huang","year":"2020","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0073","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0074","first-page":"4539","article-title":"Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19","volume":"24","author":"Meo","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0075","author":"Silva Borba","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0076","article-title":"The QT interval in patients with SARS-CoV-2 infection treated with hydroxychloroquine\/azithromycin","author":"Chorin","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ijantimicag.2020.106028_bib0077","article-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19","author":"Magagnoli","year":"2020","journal-title":"medRxiv"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920301916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920301916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:39:35Z","timestamp":1760377175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920301916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0924857920301916"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106028","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on possible modes of action of chloroquine\/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106028"}}